Loading...
XSHG
603739
Market cap436mUSD
Jul 10, Last price  
11.85CNY
1D
1.20%
1Q
-20.84%
IPO
-50.37%
Name

Qingdao Vland Biotech Co Ltd

Chart & Performance

D1W1MN
XSHG:603739 chart
P/E
42.95
P/S
2.19
EPS
0.28
Div Yield, %
0.85%
Shrs. gr., 5y
1.89%
Rev. gr., 5y
7.31%
Revenues
1.37b
+3.43%
728,223,335751,723,669781,229,944799,439,773813,970,527846,777,962960,249,3531,150,823,5641,163,162,7801,198,902,1031,320,761,0611,366,123,678
Net income
70m
+11.45%
53,234,92370,265,78282,550,44885,625,17883,384,94377,752,947108,976,214132,573,20469,842,01480,706,91462,637,48869,809,673
CFO
114m
-41.69%
58,547,60074,268,465154,487,354121,900,84485,751,37965,327,125172,997,19089,513,69995,306,379153,592,321195,407,571113,947,481
Dividend
May 30, 20250.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Qingdao Vland Biotech Inc. specializes in the research, development, and production of enzymes, probiotics, animal vaccines, and veterinary health products. Its extensive product range features enzymes for animal feed, industrial uses, and food processing, along with various probiotics, such as aquaculture premixes, general health supplements, and both animal and plant-specific formulations. The company also provides a comprehensive array of animal vaccines and biological solutions, including both live and inactivated vaccines for poultry and swine, in addition to antibodies. Its offerings extend to poultry pharmaceuticals, covering antiparasitic, antiviral, and nutritional medications, alongside disinfectants. Furthermore, it supplies traditional Chinese veterinary remedies designed for aquatic species, poultry, and livestock, including laying hens. Vland Biotech's diverse clientele operates across numerous sectors, such as agriculture, animal husbandry, textile manufacturing, papermaking, household cleaning and detergents, food production, biofuel development, and environmental protection. This entity, established in 2005 and headquartered in Qingdao, China, operates as a subsidiary of Qingdao Kangdien Industrial Co., Ltd.
IPO date
Jan 16, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT